🇺🇸 FDA
Pipeline program

SSS17

SSS17-103

Phase 1 small_molecule completed

Quick answer

SSS17 for Healthy Subjects (HS) is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Healthy Subjects (HS)
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials